Clinical trial

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

NCT00652483

Study summary

ClinicalTrials.gov

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Brimonidine ophthalmic solution 0.1% Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Brimonidine ophthalmic solution 0.2% Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-05-01

PhasePHASE3

Conditions

Glaucomaverified · MONDO: glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

Brimonidine ophthalmic solution 0.1%DRUG

Brimonidine ophthalmic solution 0.2%DRUG

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00652483 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.